NXXT caught my eye with its pre-market gain of 2.68% to $1.15, building on the announcement of a 28-year microgrid power purchase agreement with Topanga Terrace, as reported by Nasdaq. This long-term contract in the healthcare energy space could enhance revenue predictability, aligning with classic value principles of sustainable cash flows.
Fundamentally, the company has shown impressive growth, with year-to-date revenue on track for a record, including November's $7.51 million (up 271% YoY) and December's 253% increase, per StockTitan. Overall revenue growth stands at 227.2%, supporting a market cap of $151.66 million. However, the stock remains below key technical levels: 50-day MA at $1.38 and 200-day at $2.08, within a 52-week range of $0.93 to $4.34.
Yesterday's volume was 1.5 million shares, 0.7x the 3-month average of 2.1 million, suggesting room for appreciation if execution continues. From a value standpoint, this might represent a margin of safety for patient investors.
Has anyone else analyzed NXXT's fundamentals post-PPA? What do you see as the key risks or upsides at current levels?
This is not financial advice - always verify data independently.